346 related articles for article (PubMed ID: 20046965)
1. Monoclonal antibodies in the treatment of pancreatic cancer.
Huang ZQ; Buchsbaum DJ
Immunotherapy; 2009 Mar; 1(2):223-9. PubMed ID: 20046965
[TBL] [Abstract][Full Text] [Related]
2. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
[TBL] [Abstract][Full Text] [Related]
3. Genetically engineered monoclonal antibodies for direct anti-neoplastic treatment and cancer cell specific delivery of chemotherapeutic agents.
Bodey B; Bodey B; Siegel SE; Kaiser HE
Curr Pharm Des; 2000 Feb; 6(3):261-76. PubMed ID: 10637379
[TBL] [Abstract][Full Text] [Related]
4. Antibody therapy in pancreatic cancer: mAb-ye we're onto something?
Boland AJ; O'Kane AA; Buick R; Longley DB; Scott CJ
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188557. PubMed ID: 33945846
[TBL] [Abstract][Full Text] [Related]
5. Systemic treatments for metastatic cutaneous melanoma.
Pasquali S; Hadjinicolaou AV; Chiarion Sileni V; Rossi CR; Mocellin S
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011123. PubMed ID: 29405038
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic cancer: role of the immune system in cancer progression and vaccine-based immunotherapy.
Amedei A; Niccolai E; Prisco D
Hum Vaccin Immunother; 2014; 10(11):3354-68. PubMed ID: 25483688
[TBL] [Abstract][Full Text] [Related]
7. Specificity delivers: therapeutic role of tumor antigen-specific antibodies in pancreatic cancer.
Jhaveri DT; Zheng L; Jaffee EM
Semin Oncol; 2014 Oct; 41(5):559-75. PubMed ID: 25440603
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy for pancreatic cancer - science driving clinical progress.
Laheru D; Jaffee EM
Nat Rev Cancer; 2005 Jun; 5(6):459-67. PubMed ID: 15905855
[TBL] [Abstract][Full Text] [Related]
9. Future prospects of monoclonal antibodies as magic bullets in immunotherapy.
Maleki LA; Baradaran B; Majidi J; Mohammadian M; Shahneh FZ
Hum Antibodies; 2013; 22(1-2):9-13. PubMed ID: 24284304
[TBL] [Abstract][Full Text] [Related]
10. New approaches tackle rising pancreatic cancer rates.
Brower V
J Natl Cancer Inst; 2014 Dec; 106(12):. PubMed ID: 25535299
[No Abstract] [Full Text] [Related]
11. Targeted immunotherapy for colorectal cancer: monoclonal antibodies and immunotoxins.
Shapira S; Lisiansky V; Arber N; Kraus S
Expert Opin Investig Drugs; 2010 Apr; 19 Suppl 1():S67-77. PubMed ID: 20374033
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies and other targeted therapies for pancreatic cancer.
Cinar P; Tempero MA
Cancer J; 2012; 18(6):653-64. PubMed ID: 23187854
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic Antibodies in Cancer Therapy.
Gasser M; Waaga-Gasser AM
Adv Exp Med Biol; 2016; 917():95-120. PubMed ID: 27236554
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibody therapy of pancreatic cancer with cetuximab: potential for immune modulation.
Luedke E; Jaime-Ramirez AC; Bhave N; Carson WE
J Immunother; 2012 Jun; 35(5):367-73. PubMed ID: 22576341
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic potential of amanitin-conjugated anti-epithelial cell adhesion molecule monoclonal antibody against pancreatic carcinoma.
Moldenhauer G; Salnikov AV; Lüttgau S; Herr I; Anderl J; Faulstich H
J Natl Cancer Inst; 2012 Apr; 104(8):622-34. PubMed ID: 22457476
[TBL] [Abstract][Full Text] [Related]
16. Antibodies in the therapy of colon cancer.
Welt S; Ritter G
Semin Oncol; 1999 Dec; 26(6):683-90. PubMed ID: 10606261
[TBL] [Abstract][Full Text] [Related]
17. Novel agents for advanced pancreatic cancer.
Akinleye A; Iragavarapu C; Furqan M; Cang S; Liu D
Oncotarget; 2015 Nov; 6(37):39521-37. PubMed ID: 26369833
[TBL] [Abstract][Full Text] [Related]
18. Sacituzumab Govitecan (IMMU-132), an Anti-Trop-2/SN-38 Antibody-Drug Conjugate: Characterization and Efficacy in Pancreatic, Gastric, and Other Cancers.
Cardillo TM; Govindan SV; Sharkey RM; Trisal P; Arrojo R; Liu D; Rossi EA; Chang CH; Goldenberg DM
Bioconjug Chem; 2015 May; 26(5):919-31. PubMed ID: 25915780
[TBL] [Abstract][Full Text] [Related]
19. Superantigen-based immunotherapy: a phase I trial of PNU-214565, a monoclonal antibody-staphylococcal enterotoxin A recombinant fusion protein, in advanced pancreatic and colorectal cancer.
Giantonio BJ; Alpaugh RK; Schultz J; McAleer C; Newton DW; Shannon B; Guedez Y; Kotb M; Vitek L; Persson R; Gunnarsson PO; Kalland T; Dohlsten M; Persson B; Weiner LM
J Clin Oncol; 1997 May; 15(5):1994-2007. PubMed ID: 9164211
[TBL] [Abstract][Full Text] [Related]
20. Prevailing over T cell exhaustion: New developments in the immunotherapy of pancreatic cancer.
Bauer C; Kühnemuth B; Duewell P; Ormanns S; Gress T; Schnurr M
Cancer Lett; 2016 Oct; 381(1):259-68. PubMed ID: 26968250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]